• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AKT2 突变致父源嵌合体遗传性家族性胰岛素低血糖症患儿应用西罗莫司的疗效和安全性

Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father.

机构信息

SI Institute of Hereditary Pathology NAMS of Ukraine, Lviv, Ukraine.

Department of Paediatrics, Medical University of Warsaw, Warsaw, Poland.

出版信息

Eur J Med Genet. 2021 Dec;64(12):104368. doi: 10.1016/j.ejmg.2021.104368. Epub 2021 Oct 18.

DOI:10.1016/j.ejmg.2021.104368
PMID:34673243
Abstract

Activating mutation in the insulin signal-transducing kinase AKT2 results in severe hypoinsulinemic hypoketotic hypoglycemia and a characteristic phenotype of possible overgrowth and, sometimes, acanthosis nigricans. Herein, we describe a metabolic and hormonal profile before and during treatment with sirolimus in two brothers with AKT2 mutation inherited from the mosaic father, who showed low-level mosaicism in sperm. The boys, aged 1 and 14, who had severe non-insulin-dependent hypoketotic hypoglycemia and a typical dysmorphism, were admitted to endocrinology department for the analysis of their metabolic parameters: lipids, lactate, ammonia, glucose, insulin, c-peptide, and hormones (GH, IGF1, IGFBP3, TSH, fT4, cortisol, ACTH) before and during treatment with sirolimus. Previously, they had been treated with high-carbohydrate diet. The brothers were started on sirolimus with subsequent normalization of glycemia and reduced carbohydrate feedings overnight. The lowest fasting glucose levels improved from 20 mg/dl to 45 mg/dl in both sibs. The BMI of both brothers significantly dropped. After 6 months of sirolimus therapy we did not observe any laboratory or clinical side effects of the treatment.

摘要

胰岛素信号转导激酶 AKT2 的激活突变导致严重的胰岛素缺乏性低血糖伴酮血症和可能过度生长的特征表型,有时还伴有黑棘皮病。在此,我们描述了两个男孩在接受西罗莫司治疗前后的代谢和激素特征,他们均从嵌合父亲那里遗传了 AKT2 突变,而父亲的精子中存在低水平的嵌合现象。这两个男孩一个 1 岁,一个 14 岁,患有严重的非胰岛素依赖性低血糖伴酮血症和典型的畸形,他们因代谢参数分析而被收入内分泌科:治疗前后的血脂、乳酸、氨、血糖、胰岛素、C 肽和激素(GH、IGF1、IGFBP3、TSH、游离 T4、皮质醇、ACTH)。此前,他们接受了高碳水化合物饮食治疗。随后,我们给两个男孩都使用了西罗莫司,之后他们的血糖恢复正常,夜间碳水化合物摄入量减少。两个孩子的空腹血糖水平从 20mg/dl 改善到 45mg/dl。两个兄弟的 BMI 均显著下降。西罗莫司治疗 6 个月后,我们未观察到任何治疗相关的实验室或临床副作用。

相似文献

1
Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father.AKT2 突变致父源嵌合体遗传性家族性胰岛素低血糖症患儿应用西罗莫司的疗效和安全性
Eur J Med Genet. 2021 Dec;64(12):104368. doi: 10.1016/j.ejmg.2021.104368. Epub 2021 Oct 18.
2
Activating AKT2 mutation: hypoinsulinemic hypoketotic hypoglycemia.激活型AKT2突变:低胰岛素性低酮性低血糖症。
J Clin Endocrinol Metab. 2014 Feb;99(2):391-4. doi: 10.1210/jc.2013-3228. Epub 2013 Nov 27.
3
Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.由于PI3激酶的嵌合基因激活导致的低胰岛素血症、低酮血症性低血糖症。
Eur J Endocrinol. 2017 Aug;177(2):175-186. doi: 10.1530/EJE-17-0132. Epub 2017 May 31.
4
MORFAN Syndrome: An Infantile Hypoinsulinemic Hypoketotic Hypoglycemia Due to an AKT2 Mutation.莫凡综合征:一种由AKT2突变引起的婴儿期低胰岛素血症性低酮性低血糖症。
J Pediatr. 2015 Aug;167(2):489-91. doi: 10.1016/j.jpeds.2015.04.069. Epub 2015 May 23.
5
The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway.西罗莫司治疗两种伴有非酮症性低血糖的罕见疾病的疗效:mTOR 通路的作用。
J Clin Res Pediatr Endocrinol. 2020 Nov 25;12(4):439-443. doi: 10.4274/jcrpe.galenos.2020.2019.0084. Epub 2020 Mar 11.
6
An activating mutation of AKT2 and human hypoglycemia.AKT2 激活突变与人类低血糖症。
Science. 2011 Oct 28;334(6055):474. doi: 10.1126/science.1210878. Epub 2011 Oct 6.
7
Constitutive Activation of AKT2 in Humans Leads to Hypoglycemia Without Fatty Liver or Metabolic Dyslipidemia.人类中AKT2的组成性激活导致低血糖,而无脂肪肝或代谢性血脂异常。
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2914-2921. doi: 10.1210/jc.2017-00768.
8
Polymicrogyria in association with hypoglycemia points to mutation in the mTOR pathway.多小脑回畸形合并低血糖提示mTOR信号通路存在突变。
Eur J Med Genet. 2018 Dec;61(12):738-740. doi: 10.1016/j.ejmg.2018.06.002. Epub 2018 Jun 5.
9
A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism.一名患有黑棘皮病和高雄激素血症的青少年中发现一种新型胰岛素受体突变。
J Pediatr Endocrinol Metab. 2016 Oct 1;29(10):1201-1205. doi: 10.1515/jpem-2015-0384.
10
Treatment of hypoglycemia due to a rare pathogenic variant in with waxy maize heat-modified starch.用糯玉米热改性淀粉治疗由罕见致病变体引起的低血糖症。
Clin Case Rep. 2024 Feb 8;12(2):e8473. doi: 10.1002/ccr3.8473. eCollection 2024 Feb.

引用本文的文献

1
Treatment of hypoglycemia due to a rare pathogenic variant in with waxy maize heat-modified starch.用糯玉米热改性淀粉治疗由罕见致病变体引起的低血糖症。
Clin Case Rep. 2024 Feb 8;12(2):e8473. doi: 10.1002/ccr3.8473. eCollection 2024 Feb.
2
Syndromic forms of congenital hyperinsulinism.先天性高胰岛素血症的综合征形式。
Front Endocrinol (Lausanne). 2023 Mar 30;14:1013874. doi: 10.3389/fendo.2023.1013874. eCollection 2023.